1-8 of 8
Ding Zhang
Close
Sort by
Journal Articles

Clinical Efficacy Observation of Humanized BCMA-CAR-T in the Treatment of Relapsed/Refractory Multiple Myeloma Complicated with Extramedullary Lesions

Yi Wang, Hui Wang, Ben Niu, Ying Gao, Ding Zhang, Yudi Miao, Wei Zhou, Limin Hou, Hong Zhang, Xingxing Hu, Fangyuan Wang, Lan Li, Xingli Ru, Weihua Zhang, Xiang Li, Feng Guan
Journal: Blood
Blood (2022) 140 (Supplement 1): 10287.
https://doi.org/10.1182/blood-2022-168561
Published: 2022
Journal Articles

SC-gtCAR19, a Non-Viral Genome Targeting Anti-CD19 CAR-T Candidate in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: Updated Results from Long-Term Follow-up

Hui Wang, Ying Gao, Ding Zhang, Yan Zheng, Xingxing Hu, Qiuying Gao, Ben Niu, Limin Hou, Ling Wang, Weihua Zhang, Yi Zhang, Xingli Ru, Le Li, Zuohan Peng, Yi Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 4623–4624.
https://doi.org/10.1182/blood-2022-159871
Published: 2022
Journal Articles

A Preliminary Study on the Safety and Efficacy of a Novel Human BCMA-Targeting CAR-T Therapy in Patients with Relapsed/Refractory Multiple Myeloma

Yi Wang, Ying Gao, Hui Wang, Ding Zhang, Yan Zheng, Xingxing Hu, Qiuying Gao, Ben Niu, Hong Zhang, Wei Zhou, Weihua Zhang, Xingli Ru, Fangyuan Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1735.
https://doi.org/10.1182/blood-2021-152651
Published: 2021
Journal Articles

A Feasibility and Safety Study of Non-Viral Genome Targeting Anti-CD19 CAR-T in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Yi Wang, MD, Hui Wang, Master, Ying Gao, PhD, Ding Zhang, Bachelor, Yan Zheng, MD, Xingxing Hu, Master, Qiuying Gao, Master, Zuohan Peng, PhD, Le Li, Ben Niu, Master, Limin Hou, Master, Ling Wang, Bachelor, Weihua Zhang, Bachelor, Yi Zhang, Bechelor, Xingli Ru, Bachelor
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-139190
Published: 2020
Journal Articles

Mucin 20 (MUC20) Modulates Proteasome Assembly Chaperones through the c-MET Pathway and Is a Biomarker of Proteasome Inhibitor Sensitivity in Myeloma

Huihan Wang, MD, PhD, Veerabhadran Baladandayuthapani, PhD, Heather Yan Lin, PhD, Xiaobin Wang, MD, Bingzong Li, MD, PhD, Xing-Ding Zhang, PhD, Isere Kuiatse, PhD, Hua Wang, PhD, Dongmin Gu, MD, PhD, Liye Zhong, PhD, Wencai Ma, PhD, Richard E. Davis, MD, Robert Z. Orlowski, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 274.
https://doi.org/10.1182/blood.V124.21.274.274
Published: 2014
Journal Articles

Studies of the Proteasome Inhibitor Sensitivity Modulator Tight Junction Protein 1 Highlight a Role for Signaling through the Epidermal Growth Factor Receptor in Determining Proteasome Capacity

Xing-Ding Zhang, PhD, Veerabhadran Baladandayuthapani, PhD, Heather Yan Lin, PhD, George Mulligan, PhD, Bin Li, PhD, Dixie-Lee Esseltine, MD, Lin Qi, PhD, Jian-Liang Xu, PhD, Walter Hunziker, PhD, Bart Barlogie, MD, PhD, Saad Z. Usmani, MD, Qing Zhang, PhD, John Crowley, PhD, Antje Hoering, PhD, Bing-Zong Li, MD, PhD, Huihan Wang, MD, PhD, Jiexin Zhang, M.S., Isere Kuiatse, PhD, Jin-Le Tang, PhD, Jin He, Jing Yang, PhD, Richard Eric Davis, MD, Wencai Ma, PhD, Zhiqiang Wang, PhD, Lin Yang, MD, PhD, Robert Z. Orlowski, PhD MD
Journal: Blood
Blood (2014) 124 (21): 3414.
https://doi.org/10.1182/blood.V124.21.3414.3414
Published: 2014
Journal Articles

Identification Of Tight Junction Protein (TJP)-1 As a Modulator and Biomarker Of Proteasome Inhibitor Sensitivity In Multiple Myeloma

Xing-Ding Zhang, PhD, Veerabhadran Baladandayuthapani, Ph.D., Heather Yan Lin, Ph.D., Bart Barlogie, MD, PhD, Saad Z Usmani, MD, FACP, Lin Yang, Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 123.
https://doi.org/10.1182/blood.V122.21.123.123
Published: 2013
Journal Articles

Identification of Tight Junction Protein (TJP)-1 As a Modulator of Sensitivity to Doxorubicin and Cisplatin in Models of Multiple Myeloma

Xing-Ding Zhang, PhD, Robert Z. Orlowski, M.D., Ph.D., Lin Yang
Journal: Blood
Blood (2012) 120 (21): 3962.
https://doi.org/10.1182/blood.V120.21.3962.3962
Published: 2012